JP2002037709A - Skin care preparation - Google Patents

Skin care preparation

Info

Publication number
JP2002037709A
JP2002037709A JP2000221726A JP2000221726A JP2002037709A JP 2002037709 A JP2002037709 A JP 2002037709A JP 2000221726 A JP2000221726 A JP 2000221726A JP 2000221726 A JP2000221726 A JP 2000221726A JP 2002037709 A JP2002037709 A JP 2002037709A
Authority
JP
Japan
Prior art keywords
skin
thioredoxin
yeast extract
yeast
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000221726A
Other languages
Japanese (ja)
Inventor
Hitoshi Masaki
仁 正木
Yuri Okano
由利 岡野
Masumi Takei
増美 竹井
Norihisa Kawai
徳久 河合
Katsuko Minoura
克子 箕浦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Ichimaru Pharcos Co Ltd
Original Assignee
Noevir Co Ltd
Ichimaru Pharcos Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd, Ichimaru Pharcos Co Ltd filed Critical Noevir Co Ltd
Priority to JP2000221726A priority Critical patent/JP2002037709A/en
Publication of JP2002037709A publication Critical patent/JP2002037709A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a skin care preparation capable of activating the physiological function of the skin, therefore effective for preventing and ameliorating rough skin or skin aging. SOLUTION: This skin care preparation is obtained by formulating a skin care preparation base with at least one kind selected from extracts of yeast with high thioredoxin activity, wherein the yeast with high thioredoxin activity to be preferably used is a thioredoxin-rich strain isolated from Saccharomyces cerevisiae Meyer.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、皮膚の生理機能を
活性化し、肌荒れや皮膚の老化の防止及び改善に有効な
皮膚外用剤に関する。さらに詳しくは、チオレドキシン
活性の高い酵母の抽出物より選択した1種又は2種以上
を含有して成る皮膚外用剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an external preparation for skin which activates physiological functions of the skin and is effective for preventing and improving rough skin and aging of the skin. More specifically, the present invention relates to an external preparation for skin comprising one or more selected from yeast extracts having high thioredoxin activity.

【0002】[0002]

【従来の技術】酵母抽出物は皮膚保湿効果や皮膚細胞賦
活効果を有し、皮膚外用剤に汎用される成分であり、ヒ
アルロン酸産生促進効果を有することも報告されている
(特開平8−163983)。しかしながら、酵母抽出
物を配合したのみでは十分な作用効果を得ることができ
ず、他の生理活性成分と組み合わせて配合されることが
多かった。
2. Description of the Related Art Yeast extract has a skin moisturizing effect and a skin cell activating effect, is a component widely used in external preparations for the skin, and has also been reported to have a hyaluronic acid production promoting effect (Japanese Patent Laid-Open No. Hei 8-8). 163983). However, sufficient action and effect cannot be obtained only by blending the yeast extract, and the blend is often blended with other physiologically active ingredients.

【0003】一方、紫外線等種々のストレスや皮膚組織
内代謝により生じる活性酸素種が、皮膚の機能低下や老
化の発生及び進行に関与することが明らかになるにつ
れ、タンニン類,フラボノイド等のポリフェノール類や
各種植物抽出処理物等、活性酸素種を消去する成分のス
クリーニングが盛んに行われている。しかし、紫外線等
や加齢による皮膚の機能低下や老化においては、活性酸
素種の他に種々の要因が複雑に関与するため、単に活性
酸素種を消去するのみでは皮膚の機能低下や老化を十分
に防止或いは改善することは困難であった。
[0003] On the other hand, as it has been revealed that reactive oxygen species generated by various stresses such as ultraviolet rays and metabolism in skin tissues are involved in the occurrence and progression of skin function deterioration and aging, polyphenols such as tannins and flavonoids have been developed. Screening of components that eliminate reactive oxygen species, such as plant extracts and various plant extracts, has been actively conducted. However, since various factors besides reactive oxygen species are involved in the deterioration and aging of the skin due to ultraviolet rays and aging, simply erasing the reactive oxygen species is sufficient to reduce the skin function and aging. It was difficult to prevent or improve the situation.

【0004】[0004]

【発明が解決しようとする課題】そこで本発明において
は、紫外線等や加齢による皮膚の機能低下及び老化を有
効に防止及び改善することのできる皮膚外用剤を得るこ
とを目的とした。
SUMMARY OF THE INVENTION Accordingly, an object of the present invention is to provide a skin external preparation which can effectively prevent and improve the deterioration and aging of the skin due to ultraviolet rays or aging.

【0005】[0005]

【課題を解決するための手段】上記の課題を解決するべ
く種々検討した結果、酵母においてチオレドキシン活性
の高い株を見いだし、この抽出物を皮膚外用剤に配合し
たところ、非常に良好な皮膚機能活性化作用が得られ、
本発明を完成するに至った。
As a result of various studies to solve the above problems, a strain having a high thioredoxin activity in yeast was found, and this extract was incorporated into an external preparation for skin. Chemical action is obtained,
The present invention has been completed.

【0006】すなわち本発明においては、チオレドキシ
ン活性の高い酵母の抽出物より選択した1種又は2種以
上を、皮膚外用剤基剤に含有させる。なお、チオレドキ
シンはレドックス制御に関与するタンパク質であり、活
性酸素種の消去作用を有することはすでに開示されてい
る(特開平9−12471)。しかしながら、チオレド
キシン活性の高い酵母の抽出物を用いた場合には、チオ
レドキシン以外の含有成分との併用効果により、予測を
越える皮膚機能活性化作用が発揮されたのである。
That is, in the present invention, one or more selected from yeast extracts having high thioredoxin activity are contained in a skin external preparation base. It has been already disclosed that thioredoxin is a protein involved in redox control and has a function of eliminating reactive oxygen species (Japanese Patent Application Laid-Open No. 9-12471). However, when a yeast extract having a high thioredoxin activity was used, a skin function activating action that was unexpectedly exhibited was exhibited due to the combined effect with a component other than thioredoxin.

【0007】[0007]

【発明の実施の形態】本発明においては、チオレドキシ
ン活性の高い酵母の抽出物として、チオレドキシン活性
が30ユニット/ml以上のものを用いる。抽出物を得
るのに用いるチオレドキシン活性の高い酵母としては、
パン酵母であるSaccharomyces cerevisiae Meyerより分
離されたチオレドキシン高含有株が好ましく用いられ
る。
BEST MODE FOR CARRYING OUT THE INVENTION In the present invention, a yeast extract having a high thioredoxin activity having a thioredoxin activity of 30 units / ml or more is used. As yeast having high thioredoxin activity used to obtain the extract,
A thioredoxin-rich strain isolated from Saccharomyces cerevisiae Meyer, a baker's yeast, is preferably used.

【0008】本発明において用いるチオレドキシン活性
の高い酵母の抽出物としては、前記酵母の水性溶媒によ
る抽出物や加熱抽出物、酵母を自己消化,酸加水分解又
は酵素分解等により溶菌させた後ろ過したもの、或いは
前記溶菌液を乾燥し、それより水性溶媒で抽出した物を
用いることができる。
[0008] The yeast extract having a high thioredoxin activity used in the present invention includes an extract of the yeast with an aqueous solvent, a heat extract, and a yeast which has been lysed by autolysis, acid hydrolysis or enzymatic degradation and then filtered. Or a product obtained by drying the lysate and extracting it with an aqueous solvent.

【0009】抽出溶媒としては、水の他、生理食塩水,
リン酸緩衝液,リン酸緩衝生理食塩水等の水性溶媒を用
いることができ、これらより1種又は2種以上を選択し
て用いる。酵母は乾燥及び/又は粉砕してから抽出に供
してもよく、抽出溶媒中でホモジナイズしたり、超音波
破砕を行ってもよい。また培地中で紫外線照射して、抽
出物を得ることもできる。抽出温度としては、0℃程度
から抽出溶媒の沸点以下の温度とするのが適切である。
抽出時間は抽出溶媒の種類や抽出温度及び抽出方法によ
っても異なるが、1時間〜5日間程度とするのが好まし
い。
As an extraction solvent, in addition to water, physiological saline,
Aqueous solvents such as a phosphate buffer and a phosphate buffered saline can be used, and one or two or more thereof are selected and used. The yeast may be dried and / or pulverized before being subjected to extraction, or may be homogenized in an extraction solvent or subjected to sonication. The extract can also be obtained by irradiating the medium with ultraviolet light. It is appropriate that the extraction temperature is set to a temperature from about 0 ° C. to the boiling point of the extraction solvent or lower.
The extraction time varies depending on the type of extraction solvent, the extraction temperature and the extraction method, but is preferably about 1 hour to 5 days.

【0010】酵母の上記極性溶媒による抽出物は、その
ままでも本発明に係る皮膚外用剤に含有させることがで
きるが、濃縮,乾固したり、又は濃縮,乾固物を水性溶
媒に再度溶解したり、或いは皮膚機能活性化作用を損な
わない範囲で脱色,脱臭,脱塩等の精製処理や分散処理
を行った後に用いてもよい。また保存のため、精製処理
の後凍結乾燥し、用時に溶媒に溶解して用いることもで
きる。また、リポソーム等のベシクルやマイクロカプセ
ル等に内包させて含有させることもできる。
The extract of yeast with the above-mentioned polar solvent can be contained in the external preparation for skin according to the present invention as it is. However, the extract is concentrated and dried, or the concentrated and dried product is dissolved again in an aqueous solvent. Alternatively, it may be used after purifying or dispersing such as decolorization, deodorization, and desalting within a range that does not impair the skin function activating action. For preservation, it can be freeze-dried after the purification treatment and dissolved in a solvent before use. Further, it may be contained in vesicles such as liposomes or microcapsules.

【0011】なお、チオレドキシン活性の高い酵母の抽
出物は、上記したようにして調製したものを用いてもよ
いが、一丸ファルコス株式会社より販売されている「イ
ーストリキッドTRX」等の市販原料を用いてもよい。
本発明においては、これら酵母抽出物より1種又は2種
以上を選択して用いる。皮膚外用剤全量当たりの含有量
としては特に限定されないが、その生理機能や皮膚外用
剤製剤のバイオアベイラビリティから、0.0001〜
10.0重量%程度とするのが適切である。
The yeast extract having a high thioredoxin activity may be prepared as described above, but may be prepared using commercially available materials such as "East Liquid TRX" sold by Ichimaru Falcos Co., Ltd. You may.
In the present invention, one or more of these yeast extracts are selected and used. The content per total amount of the external preparation for skin is not particularly limited, but from the physiological function and the bioavailability of the external preparation for skin, 0.0001 to
Suitably, it is about 10.0% by weight.

【0012】本発明に係る皮膚外用剤は、ローション
剤,乳剤,ゲル剤,クリーム剤,軟膏剤,散剤,顆粒
剤,粉末剤等の剤型で提供することができる。また、化
粧水,乳液,クリーム,パック等の皮膚化粧料、メイク
アップベースローション,メイクアップベースクリー
ム,乳液状,クリーム状,軟膏型,粉末状等のファンデ
ーション,アイカラー,チークカラーといったメイクア
ップ化粧料、ハンドクリーム,レッグクリーム,ボディ
ローション等の身体用化粧料などとしても提供すること
ができる。
The external preparation for skin according to the present invention can be provided in the form of lotions, emulsions, gels, creams, ointments, powders, granules, powders and the like. Also, skin cosmetics such as lotions, emulsions, creams, packs, etc., makeup base lotions, makeup base creams, foundations such as emulsions, creams, ointments, powders, etc., makeups such as eye colors and cheek colors. , Hand creams, leg creams, body lotions and other body cosmetics.

【0013】また本発明に係る皮膚外用剤には、チオレ
ドキシン活性の高い酵母抽出物の1種又は2種以上の他
に、油類,界面活性剤,保湿剤,エモリエント剤,顔
料,香料,紫外線吸収剤,紫外線散乱剤,抗酸化剤,防
菌防黴剤等の一般的な医薬品及び化粧料用原料や、活性
酸素消去剤,抗炎症剤,美白剤,皮膚細胞賦活剤,抗変
異原性作用を有する成分,紫外線による免疫機能低下抑
制作用を有する成分等の生理活性成分をも含有させるこ
とができる。
The external preparation for skin according to the present invention includes, in addition to one or more yeast extracts having high thioredoxin activity, oils, surfactants, humectants, emollients, pigments, fragrances, and ultraviolet rays. Raw materials for general pharmaceuticals and cosmetics such as absorbers, ultraviolet light scattering agents, antioxidants, antibacterial and fungicides, active oxygen scavengers, anti-inflammatory agents, whitening agents, skin cell activators, anti-mutagenicity Physiologically active components such as a component having an action and a component having a function of suppressing a decrease in immune function due to ultraviolet rays can also be contained.

【0014】さらに本発明の特徴について、実施例によ
り詳細に説明する。
Further, the features of the present invention will be described in detail with reference to examples.

【0015】[0015]

【実施例】まず、本発明で用いるチオレドキシン活性の
高い酵母抽出物の調製例を示す。
First, a preparation example of a yeast extract having a high thioredoxin activity used in the present invention will be described.

【0016】[チオレドキシン高活性酵母抽出物1]Sa
ccharomyces cerevisiae Meyerより分離されたチオレド
キシン高含有株の乾燥粉末200gに精製水2リットル
を加え、室温にて24時間静置して自己消化を行わせた
後、60℃〜80℃にて4時間処理した。次いでメンブ
ランフィルターにてろ過,滅菌し、標記酵母抽出物とし
た。
[Thioredoxin highly active yeast extract 1] Sa
2 liters of purified water was added to 200 g of a dry powder of a thioredoxin-rich strain isolated from ccharomyces cerevisiae Meyer, and allowed to stand at room temperature for 24 hours to allow autolysis, followed by treatment at 60 ° C. to 80 ° C. for 4 hours. did. Then, it was filtered and sterilized with a membrane filter to obtain the title yeast extract.

【0017】[チオレドキシン高活性酵母抽出物2]Sa
ccharomyces cerevisiae Meyerより分離されたチオレド
キシン高含有株を培養し、菌体500gを精製水中にて
自己消化させて得た溶菌液をメンブランフィルターにて
ろ過,滅菌し、濃縮した後凍結乾燥し、次いでこれをリ
ン酸緩衝生理食塩水500ml中に浸漬し、15℃で3
日間撹拌抽出した後、ろ過してろ液を回収し、標記酵母
抽出物とした。
[Thioredoxin highly active yeast extract 2] Sa
A thioredoxin-rich strain isolated from ccharomyces cerevisiae Meyer is cultured, and a lysate obtained by autolyzing 500 g of cells in purified water is filtered through a membrane filter, sterilized, concentrated, lyophilized, and then lyophilized. Immersed in 500 ml of phosphate buffered saline, and
After stirring and extracting for days, the filtrate was collected by filtration and used as the title yeast extract.

【0018】[チオレドキシン高活性酵母抽出物3]Sa
ccharomyces cerevisiae Meyerより分離されたチオレド
キシン高含有株を培養し、菌体500gを酸分解して得
た溶菌液をメンブランフィルターにてろ過,滅菌し、ろ
液を濃縮した後精製水500mlに溶解して、標記酵母
抽出物とした。
[Thioredoxin highly active yeast extract 3] Sa
A thioredoxin-rich strain isolated from ccharomyces cerevisiae Meyer is cultured, and a lysate obtained by acid-decomposing 500 g of cells is filtered and sterilized with a membrane filter, and the filtrate is concentrated and then dissolved in 500 ml of purified water. And the title yeast extract.

【0019】[チオレドキシン高活性酵母抽出物4]Sa
ccharomyces cerevisiae Meyerより分離されたチオレド
キシン高含有株の乾燥粉末200gに精製水2リットル
を加え、2時間加熱抽出を行った。抽出液を冷却した後
メンブランフィルターにてろ過,滅菌し、ろ液を凍結乾
燥して、標記酵母抽出物とした。
[Thioredoxin highly active yeast extract 4] Sa
Two liters of purified water was added to 200 g of the dry powder of the thioredoxin-rich strain isolated from ccharomyces cerevisiae Meyer, and the mixture was heated and extracted for 2 hours. After cooling, the extract was filtered and sterilized with a membrane filter, and the filtrate was freeze-dried to obtain the title yeast extract.

【0020】上記において調製したチオレドキシン高活
性酵母抽出物について、タンパク質含量及びチオレドキ
シン活性を定量した結果を表1に示した。なお、チオレ
ドキシン高活性酵母抽出物4については、1.0重量%
水溶液について定量を行った。また比較のため、チオレ
ドキシン活性を示す野生株のSaccharomyces cerevisiae
Meyerの乾燥粉末200gに精製水2リットルを加え、
室温にて24時間静置して自己消化を行わせた後、60
℃〜80℃にて4時間処理し、メンブランフィルターに
てろ過,滅菌して得た抽出物についての定量結果も併せ
て示した。
The results of quantification of the protein content and thioredoxin activity of the thioredoxin highly active yeast extract prepared above are shown in Table 1. In addition, about thioredoxin high activity yeast extract 4, 1.0 weight%
Quantification was performed on the aqueous solution. For comparison, a wild strain of Saccharomyces cerevisiae showing thioredoxin activity was also used.
Add 200 liters of purified water to 200 g of Meyer dry powder,
After standing at room temperature for 24 hours to allow autolysis, 60
The results of quantification of the extract obtained by treating at 4 ° C. to 80 ° C. for 4 hours and filtering and sterilizing with a membrane filter are also shown.

【0021】[0021]

【表1】 [Table 1]

【0022】表1において、チオレドキシン高活性酵母
抽出物はいずれも9.3mg/ml以上のタンパク質を
含有し、32.5ユニット/ml以上のチオレドキシン
活性を示していた。一方野生株の酵母抽出物では、タン
パク質含量はチオレドキシン高含有株抽出物と同程度で
あったが、チオレドキシン活性は15.0ユニット/m
lと、チオレドキシン高含有株抽出物の1/2以下であ
った。
In Table 1, all the thioredoxin highly active yeast extracts contained 9.3 mg / ml or more of protein, and showed thioredoxin activity of 32.5 units / ml or more. On the other hand, in the yeast extract of the wild strain, the protein content was almost the same as that of the thioredoxin-rich extract, but the thioredoxin activity was 15.0 units / m2.
and 1 / or less of the extract of the strain containing high thioredoxin.

【0023】次に、本発明に係る皮膚外用剤についての
実施例の処方を示す。
Next, the formulations of the examples of the external preparation for skin according to the present invention are shown.

【0024】 [実施例1] 化粧水 (1)エタノール 20.00(重量%) (2)ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.00 (3)香料 0.10 (4)パラオキシ安息香酸メチル 0.10 (5)ジプロピレングリコール 5.00 (6)1,3-ブチレングリコール 10.00 (7)チオレドキシン高活性酵母抽出物1 0.05 (8)精製水 63.75 製法:(1)に(2)〜(4)を添加して溶解し、アルコール相
とする。一方、(8)に(5)〜(7)を順次溶解して水相とす
る。水相にアルコール相を添加し、撹拌,混合する。
[Example 1] Lotion (1) Ethanol 20.00 (% by weight) (2) Polyoxyethylene (60E.O.) hydrogenated castor oil 1.00 (3) Fragrance 0.10 (4) Paraoxy Methyl benzoate 0.10 (5) Dipropylene glycol 5.00 (6) 1,3-butylene glycol 10.00 (7) Thioredoxin highly active yeast extract 1 0.05 (8) Purified water 63.75 Production method: (2) to (4) are added to (1) and dissolved to form an alcohol phase. On the other hand, (5) to (7) are sequentially dissolved in (8) to form an aqueous phase. Add the alcohol phase to the aqueous phase, stir and mix.

【0025】 [実施例2] 水中油型乳液 (1)オレイン酸オレイルエステル 5.0(重量%) (2)ジメチルポリシロキサン 3.0 (3)ワセリン 0.5 (4)セタノール 1.0 (5)ソルビタンセスキオレイン酸エステル 0.8 (6)ポリオキシエチレン(20E.O.)オレイルエーテル 1.2 (7)酢酸トコフェロール 0.2 (8)ジプロピレングリコール 6.0 (9)ヒドロキシエチルセルロース 0.3 (10)パラオキシ安息香酸メチル 0.1 (11)精製水 78.8 (12)エタノール 3.0 (13)チオレドキシン高活性酵母抽出物2 0.1 製法:(1)〜(6)の油相成分を混合,加熱溶解して70℃
とする。一方、(8)〜(11)の水相成分を混合,加熱溶解
して70℃とし、これに前記油相を加えてホモジナイザ
ーにて乳化し、冷却後40℃にて(12)及び(13)を順次添
加,混合する。
Example 2 Oil-in-Water Emulsion (1) Oleyl oleate 5.0 (% by weight) (2) Dimethylpolysiloxane 3.0 (3) Vaseline 0.5 (4) Cetanol 1.0 ( 5) Sorbitan sesquioleate 0.8 (6) Polyoxyethylene (20E.O.) oleyl ether 1.2 (7) Tocopherol acetate 0.2 (8) Dipropylene glycol 6.0 (9) Hydroxyethyl cellulose 0 0.3 (10) Methyl paraoxybenzoate 0.1 (11) Purified water 78.8 (12) Ethanol 3.0 (13) Thioredoxin highly active yeast extract 2 0.1 Production method: (1) to (6) Mix the oil phase components, heat and dissolve to 70 ° C
And On the other hand, the aqueous phase components (8) to (11) were mixed and dissolved by heating to 70 ° C., and the oil phase was added thereto, emulsified by a homogenizer, cooled, and cooled to 40 ° C. at (12) and (13). ) Are sequentially added and mixed.

【0026】 [実施例3] 水中油型クリーム剤 (1)ミツロウ 6.0(重量%) (2)セタノール 5.0 (3)還元ラノリン 8.0 (4)スクワラン 27.5 (5)グリセリル脂肪酸エステル 4.0 (6)親油型グリセリルモノステアリン酸エステル 2.0 (7)ポリオキシエチレン(20E.O.)ソルビタン 5.0 モノラウリン酸エステル (8)プロピレングリコール 5.0 (9)パラオキシ安息香酸メチル 0.1 (10)精製水 37.0 (11)チオレドキシン高活性酵母抽出物3 0.2 (12)チオレドキシン高活性酵母抽出物4 0.2 製法:(1)〜(7)の油相成分を混合,溶解して75℃とす
る。一方、(8)〜(10)の水相成分を混合,溶解して75
℃に加熱する。次いで、この水相成分に前記油相成分を
添加して予備乳化した後ホモミキサーにて均一に乳化
し、冷却後40℃にて(11),(12)を添加,混合する。
[Example 3] Oil-in-water cream (1) Beeswax 6.0 (wt%) (2) Cetanol 5.0 (3) Reduced lanolin 8.0 (4) Squalane 27.5 (5) Glyceryl Fatty acid ester 4.0 (6) Lipophilic glyceryl monostearate 2.0 (7) Polyoxyethylene (20E.O.) sorbitan 5.0 Monolaurate (8) Propylene glycol 5.0 (9) Paraoxy Methyl benzoate 0.1 (10) Purified water 37.0 (11) Highly active thioredoxin yeast extract 3 0.2 (12) Highly active thioredoxin yeast extract 4 0.2 Production method: (1) to (7) The oil phase components are mixed and dissolved to 75 ° C. On the other hand, the aqueous phase components (8) to (10)
Heat to ° C. Next, the oil phase component is added to the water phase component, preliminarily emulsified, and then uniformly emulsified by a homomixer. After cooling, (11) and (12) are added and mixed at 40 ° C.

【0027】 [実施例4] 油中水型日焼け止めクリーム (1)流動パラフィン 30.0(重量%) (2)マイクロクリスタリンワックス 2.0 (3)ワセリン 5.0 (4)ジグリセリルジオレイン酸エステル 5.0 (5)L-グルタミン酸ナトリウム 1.6 (6)L-セリン 0.4 (7)パラメトキシ桂皮酸オクチル 3.0 (8)オキシベンゾン 2.0 (9)4-tert-ブチル-4'-メトキシジベンゾイルメタン 0.5 (10)シリコーン処理微粒子酸化チタン 3.0 (11)プロピレングリコール 3.0 (12)パラオキシ安息香酸メチル 0.1 (13)チオレドキシン高活性酵母抽出物1 0.5 (14)精製水 43.8 (15)香料 0.1 製法:(5),(6)を(14)の一部に溶解して50℃とし、あ
らかじめ50℃に加温した(4)に撹拌しながら徐々に添
加する。これをあらかじめ混合し、70℃に加熱溶解し
た(1)〜(3)に均一に分散し、次いで(7)〜(10)を添加し
て均一に混合,分散する。これに、(11)〜(13)を(14)の
残部に溶解して70℃に加熱したものを撹拌しながら添
加し、ホモミキサーにて乳化する。冷却後、50℃にて
(15)を添加,混合する。
Example 4 Water-in-Oil Sunscreen Cream (1) Liquid Paraffin 30.0 (% by weight) (2) Microcrystalline Wax 2.0 (3) Vaseline 5.0 (4) Diglyceryl Diolein Acid ester 5.0 (5) sodium L-glutamate 1.6 (6) L-serine 0.4 (7) octyl paramethoxycinnamate 3.0 (8) oxybenzone 2.0 (9) 4-tert-butyl- 4'-methoxydibenzoylmethane 0.5 (10) Silicon-treated fine particle titanium oxide 3.0 (11) Propylene glycol 3.0 (12) Methyl parahydroxybenzoate 0.1 (13) Thioredoxin Highly active yeast extract 10 5.5 (14) Purified water 43.8 (15) Fragrance 0.1 Production method: (5), (6) was dissolved in a part of (14) to 50 ° C, and preliminarily heated to 50 ° C. ) Add slowly with stirring I do. This is mixed in advance and uniformly dispersed in (1) to (3) heated and dissolved at 70 ° C. Then, (7) to (10) are added and uniformly mixed and dispersed. A solution obtained by dissolving (11) to (13) in the remainder of (14) and heating to 70 ° C. is added thereto with stirring, and emulsified by a homomixer. After cooling, at 50 ° C
Add (15) and mix.

【0028】 [実施例5] ゲル剤 (1)ジプロピレングリコール 10.0(重量%) (2)カルボキシビニルポリマー 0.5 (3)水酸化カリウム 0.1 (4)パラオキシ安息香酸メチル 0.1 (5)精製水 88.6 (6)チオレドキシン高活性酵母抽出物2 0.5 (7)セイヨウトチノキ抽出物 0.2 製法:(5)に(2)を均一に溶解した後、(1)に(4)を溶解し
て添加し、次いで(3)を加えて増粘させ、(6),(7)を順
次添加,混合する。なお、セイヨウトチノキ抽出物は、
セイヨウトチノキの実250gを乾燥,粉砕し、50容
量%エタノール水溶液中に浸漬して20℃で5日間抽出
し、ろ過して得た。
Example 5 Gel (1) Dipropylene glycol 10.0 (% by weight) (2) Carboxyvinyl polymer 0.5 (3) Potassium hydroxide 0.1 (4) Methyl paraoxybenzoate 1 (5) Purified water 88.6 (6) Thioredoxin highly active yeast extract 2 0.5 (7) Horse chestnut extract 0.2 Production method: After uniformly dissolving (2) in (5), (1) (4) is dissolved and added to), then (3) is added to increase the viscosity, and (6) and (7) are sequentially added and mixed. In addition, the horse chestnut extract is
250 g of horse chestnut fruit was dried, pulverized, immersed in a 50% by volume aqueous ethanol solution, extracted at 20 ° C. for 5 days, and filtered.

【0029】 [実施例6] リポソーム剤 (1)グリセリン 2.0(重量%) (2)1,3-ブチレングリコール 3.0 (3)ポリオキシエチレン(25E.O.)オレイルエーテル 0.2 (4)エタノール 10.0 (5)パラオキシ安息香酸メチル 0.1 (6)香料 0.1 (7)精製水 79.6 (8)チオレドキシン高活性酵母抽出物4 5.0 内包リポソーム 製法:(5),(6)を(4)に溶解し、(1)〜(3)とともに(7)に
添加して均一に混合し、これに(8)を加えて分散する。
なお、(8)のチオレドキシン内包リポソームは、チオレ
ドキシン高活性酵母抽出物4の5.0重量%水溶液10
0mlに大豆レシチン80gを添加して55℃で懸濁
し、次いで超音波処理してリポソームを調製し、遠心分
離により回収して調製した。
Example 6 Liposomal Agent (1) Glycerin 2.0 (% by weight) (2) 1,3-butylene glycol 3.0 (3) Polyoxyethylene (25E.O.) oleyl ether 0.2 (4) Ethanol 10.0 (5) Methyl parahydroxybenzoate 0.1 (6) Fragrance 0.1 (7) Purified water 79.6 (8) Thioredoxin highly active yeast extract 4 5.0 Encapsulated liposome Production method: ( 5) and (6) are dissolved in (4), added to (7) together with (1) to (3), mixed uniformly, and dispersed by adding (8).
The thioredoxin-encapsulated liposome of (8) is a 5.0% by weight aqueous solution of thioredoxin highly active yeast extract 4 in 10% by weight.
80 g of soybean lecithin was added to 0 ml, suspended at 55 ° C., then sonicated to prepare liposomes, and recovered by centrifugation to prepare.

【0030】 [実施例7] 水中油型乳剤型軟膏 (1)白色ワセリン 25.00(重量%) (2)ステアリルアルコール 25.00 (3)グリセリン 12.00 (4)ラウリル硫酸ナトリウム 1.00 (5)リポ酸 0.02 (6)パラオキシ安息香酸メチル 0.10 (7)チオレドキシン高活性酵母抽出物3 0.15 (8)精製水 36.73 製法:(1)〜(5)の油相成分を混合,加熱して均一に溶解
し、75℃とする。一方、(6)〜(8)の水相成分を混合,
加熱して75℃とする。この水相成分に前記油相成分を
撹拌しながら徐々に添加して乳化し、冷却する。
Example 7 Oil-in-water emulsion ointment (1) White petrolatum 25.00 (% by weight) (2) Stearyl alcohol 25.00 (3) Glycerin 12.00 (4) Sodium lauryl sulfate 1.00 (5) Lipoic acid 0.02 (6) Methyl paraoxybenzoate 0.10 (7) Thioredoxin highly active yeast extract 3 0.15 (8) Purified water 36.73 Production method: Oil of (1) to (5) The phase components are mixed and heated to uniformly dissolve and brought to 75 ° C. On the other hand, the aqueous phase components (6) to (8) are mixed,
Heat to 75 ° C. The oil phase component is gradually added to the water phase component with stirring, emulsified, and cooled.

【0031】 [実施例8] メイクアップベースクリーム (1)ステアリン酸 12.0(重量%) (2)セタノール 2.0 (3)グリセリルトリ2-エチルヘキサン酸エステル 2.5 (4)自己乳化型グリセリルモノステアリン酸 2.0 エステル (5)プロピレングリコール 10.0 (6)水酸化カリウム 0.3 (7)パラオキシ安息香酸メチル 0.1 (8)精製水 68.4 (9)酸化チタン 2.0 (10)ベンガラ 0.4 (11)黄酸化鉄 0.1 (12)チオレドキシン高活性酵母抽出物1 0.1 (13)香料 0.1 製法:(1)〜(4)の油相成分を混合,溶解して75℃とす
る。一方、(5)〜(8)の水相成分を混合,加熱溶解し、こ
れに(9)〜(11)の顔料成分を添加してホモミキサーにて
均一に分散して75℃とする。次いで、この水相成分に
前記油相成分を添加してホモミキサーにて均一に乳化
し、冷却後40℃にて(12),(13)を添加,混合する。
Example 8 Makeup Base Cream (1) Stearic acid 12.0 (% by weight) (2) Cetanol 2.0 (3) Glyceryl tri-2-ethylhexanoate 2.5 (4) Self-emulsification Glyceryl monostearic acid 2.0 ester (5) Propylene glycol 10.0 (6) Potassium hydroxide 0.3 (7) Methyl paraoxybenzoate 0.1 (8) Purified water 68.4 (9) Titanium oxide 2 0.0 (10) Bengala 0.4 (11) Yellow iron oxide 0.1 (12) Highly active thioredoxin yeast extract 1 0.1 (13) Fragrance 0.1 Production method: oil phase of (1) to (4) Mix and dissolve the ingredients to 75 ° C. On the other hand, the aqueous phase components (5) to (8) are mixed and dissolved by heating, and the pigment components (9) to (11) are added thereto and uniformly dispersed by a homomixer to 75 ° C. Next, the oil phase component is added to the aqueous phase component, and the mixture is uniformly emulsified by a homomixer. After cooling, (12) and (13) are added and mixed at 40 ° C.

【0032】 [実施例9] 美白用乳液状ファンデーション (1)ステアリン酸 2.00(重量%) (2)スクワラン 5.00 (3)ミリスチン酸オクチルドデシル 5.00 (4)セタノール 1.00 (5)デカグリセリルモノイソパルミチン酸エステル 9.00 (6)1,3-ブチレンクリコール 6.00 (7)水酸化カリウム 0.08 (8)パラオキシ安息香酸メチル 0.10 (9)チオレドキシン高活性酵母抽出物2 0.01 (10)精製水 53.51 (11)酸化チタン 9.00 (12)タルク 7.40 (13)ベンガラ 0.50 (14)黄酸化鉄 1.10 (15)黒酸化鉄 0.10 (16)香料 0.15 (17)イタドリ抽出物 0.05 製法:(1)〜(5)の油相成分を混合,溶解して75℃とす
る。一方、(6)〜(10)の水相成分を混合,加熱溶解し、
これに(11)〜(15)の顔料成分を添加してホモミキサーに
て均一に分散して75℃とする。次いで、この水相成分
に前記油相成分を添加してホモミキサーにて均一に乳化
し、冷却後40℃にて(16),(17)を添加,混合する。な
お(17)のイタドリ抽出物は、イタドリの根250gを乾
燥,粉砕し、50容量%エタノール水溶液1.5リット
ル中にて20℃で7日間浸漬した後、ろ過してろ液を回
収して得た。
Example 9 Emulsion Foundation for Whitening (1) Stearic Acid 2.00 (% by weight) (2) Squalane 5.00 (3) Octyldodecyl myristate 5.00 (4) Cetanol 1.00 ( 5) Decaglyceryl monoisopalmitate 9.00 (6) 1,3-butylene crychol 6.00 (7) Potassium hydroxide 0.08 (8) Methyl parahydroxybenzoate 0.10 (9) High activity of thioredoxin Yeast extract 2 0.01 (10) Purified water 53.51 (11) Titanium oxide 9.00 (12) Talc 7.40 (13) Bengala 0.50 (14) Yellow iron oxide 1.10 (15) Black Iron oxide 0.10 (16) Fragrance 0.15 (17) Knotweed extract 0.05 Production method: Mix and dissolve oil phase components (1) to (5) to 75 ° C. On the other hand, the aqueous phase components (6) to (10) were mixed and dissolved by heating.
The pigment components (11) to (15) are added thereto, and the mixture is uniformly dispersed with a homomixer to 75 ° C. Next, the oil phase component is added to the aqueous phase component, and the mixture is uniformly emulsified by a homomixer. After cooling, (16) and (17) are added and mixed at 40 ° C. The knotweed extract of (17) was obtained by drying and pulverizing 250 g of knotweed root, immersing it in 1.5 liters of a 50% by volume aqueous ethanol solution at 20 ° C. for 7 days, and collecting the filtrate by filtration. Was.

【0033】 [実施例10] 日焼け止め用油中水型クリーム状ファンデーション (1)流動パラフィン 5.00(重量%) (2)デカメチルシクロペンタシロキサン 12.00 (3)ポリオキシエチレン変性ジメチルポリ 4.00 シロキサン (4)パラメトキシ桂皮酸オクチル 5.00 (5)オキシベンゾン 2.50 (6)1,3-ブチレングリコール 5.00 (7)ポリオキシエチレン(20E.O.)ソルビタン 2.00 モノラウリン酸エステル (8)パラオキシ安息香酸メチル 0.10 (9)チオレドキシン高活性酵母抽出物2 0.02 (10)精製水 44.28 (11)セリサイト 5.36 (12)カオリン 4.00 (13)微粒子酸化チタン 9.32 (14)ベンガラ 0.36 (15)黄酸化鉄 0.80 (16)黒酸化鉄 0.16 (17)香料 0.10 製法:(6)〜(10)の水相成分を混合して70℃に加熱
し、あらかじめ混合,粉砕した(11)〜(16)の粉体成分を
添加し、ホモミキサーにて処理する。一方、(1)〜(5)の
油相成分を混合,加熱して70℃として加え、70℃で
ホモミキサー処理する。次いで撹拌しながら冷却し、4
5℃にて(17)を加え、室温まで冷却して脱気後容器に充
填する。
Example 10 Water-in-oil Cream Foundation for Sunscreen (1) Liquid Paraffin 5.00 (% by weight) (2) Decamethylcyclopentasiloxane 12.00 (3) Polyoxyethylene-modified dimethylpoly 4.00 Siloxane (4) Octyl paramethoxycinnamate 5.00 (5) Oxybenzone 2.50 (6) 1,3-butylene glycol 5.00 (7) Polyoxyethylene (20E.O.) Sorbitan 2.00 Monolaurin Acid ester (8) Methyl parahydroxybenzoate 0.10 (9) Thioredoxin highly active yeast extract 2 0.02 (10) Purified water 44.28 (11) Sericite 5.36 (12) Kaolin 4.00 (13) ) Fine particle titanium oxide 9.32 (14) Bengala 0.36 (15) Yellow iron oxide 0.80 (16) Black iron oxide 0.16 (17) Fragrance 0.10 Production method: The aqueous phase components of (6) to (10) are mixed and heated to 70 ° C., and the powder components of (11) to (16), which have been mixed and ground in advance, are added, and the mixture is homogenized with a homomixer. To process. On the other hand, the oil phase components (1) to (5) are mixed, heated to 70 ° C., added, and homomixed at 70 ° C. Then, cool while stirring.
Add (17) at 5 ° C., cool to room temperature, deaerate and fill in a container.

【0034】 [実施例11] パウダーファンデーション (1)流動パラフィン 5.0(重量%) (2)ミリスチン酸オクチルドデシル 2.5 (3)ワセリン 2.5 (4)パラオキシ安息香酸メチル 0.1 (5)香料 0.1 (6)チオレドキシン高活性酵母抽出物4 0.1 (7)ナイロンパウダー 10.0 (8)マイカ 20.0 (9)タルク 43.8 (10)酸化チタン 9.9 (11)ベンガラ 3.0 (12)黄酸化鉄 2.5 (13)黒酸化鉄 0.5 製法:(6)〜(13)の粉体成分を混合し、粉砕機を通して
粉砕する。これを高速ブレンダーに移し、(1)〜(5)を混
合して加え、均一に混合する。これを粉砕機で処理し、
ふるいを通し粒度をそろえた後、金皿に充填して圧縮成
形する。
Example 11 Powder Foundation (1) Liquid paraffin 5.0 (% by weight) (2) Octyldodecyl myristate 2.5 (3) Vaseline 2.5 (4) Methyl parahydroxybenzoate 0.1 ( 5) Fragrance 0.1 (6) Highly active thioredoxin yeast extract 4 0.1 (7) Nylon powder 10.0 (8) Mica 20.0 (9) Talc 43.8 (10) Titanium oxide 9.9 ( 11) Bengala 3.0 (12) Yellow iron oxide 2.5 (13) Black iron oxide 0.5 Production method: The powder components of (6) to (13) are mixed and pulverized through a pulverizer. This is transferred to a high-speed blender, and (1) to (5) are mixed and added, and mixed uniformly. This is processed in a crusher,
After passing through a sieve to adjust the particle size, the mixture is filled in a metal plate and compression molded.

【0035】 [実施例12] ハンドクリーム (1)セタノール 4.00(重量%) (2)ワセリン 2.00 (3)流動パラフィン 10.00 (4)グリセリルモノステアリン酸エステル 1.50 (5)ポリオキシエチレン(60E.O.)グリセリル 2.50 イソステアリン酸エステル (6)酢酸トコフェロール 0.25 (7)グリセリン 20.00 (8)パラオキシ安息香酸メチル 0.10 (9)チオレドキシン高活性酵母抽出物1 0.15 (10)チオレドキシン高活性酵母抽出物3 0.15 (11)グリチルリチン酸ジカリウム 0.10 (12)精製水 59.25 製法:(1)〜(6)の油相成分を混合,溶解して75℃とす
る。一方、(7)〜(12)の水相成分を混合,加熱溶解して
75℃とする。次いで、この水相成分に前記油相成分を
添加してホモミキサーにて均一に乳化する。
Example 12 Hand Cream (1) Cetanol 4.00 (% by weight) (2) Vaseline 2.00 (3) Liquid paraffin 10.00 (4) Glyceryl monostearate 1.50 (5) Polyoxyethylene (60E.O.) glyceryl 2.50 Isostearate (6) Tocopherol acetate 0.25 (7) Glycerin 20.00 (8) Methyl parahydroxybenzoate 0.10 (9) Thioredoxin highly active yeast extract 1 0.15 (10) Thioredoxin highly active yeast extract 3 0.15 (11) Dipotassium glycyrrhizinate 0.10 (12) Purified water 59.25 Production method: Mix oil phase components (1) to (6), Dissolve to 75 ° C. On the other hand, the aqueous phase components (7) to (12) are mixed and dissolved by heating to 75 ° C. Next, the oil phase component is added to the aqueous phase component, and the mixture is uniformly emulsified by a homomixer.

【0036】上記した本発明に係る皮膚外用剤について
の実施例のうち、実施例1〜実施例7及び実施例12に
ついて、中波長紫外線(UVB)による皮膚のしわ形成
に対する抑制効果を評価した。その際各実施例におい
て、それぞれ配合したチオレドキシン高活性酵母抽出物
1〜4を、通常のチオレドキシン活性を示す野生株のSa
ccharomyces cerevisiae Meyerを用いて同様に調製した
酵母抽出物に代替したものを比較例1〜比較例7及び比
較例12とし、同時に評価を行った。評価は、ヘアレス
マウス5匹を1群とし、各群について実施例及び比較例
をそれぞれ1日1回背部に塗布し、100mJ/cm2
/回のUVBを1週間に3回、20週間照射し、ヘアレ
スマウス皮膚におけるしわの形成状況を観察し、表2に
示す判定基準に従って点数化して評価した。この際、精
製水のみを塗布した群を対照とした。結果は各群の平均
値を算出し、UVB照射日数との関係により表3に示し
た。
Of the above examples of the external preparation for skin according to the present invention, Examples 1 to 7 and Example 12 were evaluated for the effect of suppressing the formation of wrinkles on the skin by medium wavelength ultraviolet (UVB). At that time, in each Example, the thioredoxin highly active yeast extracts 1 to 4 which were respectively mixed were used as wild-type Sa strains showing normal thioredoxin activity.
Comparative examples 1 to 7 and 12 were used as substitutes for the yeast extract similarly prepared using ccharomyces cerevisiae Meyer, and the evaluation was performed simultaneously. For evaluation, five hairless mice were used as one group, and the examples and the comparative examples were applied to the back once a day for each group, and 100 mJ / cm 2.
UVB was irradiated three times a week for 20 weeks, and the formation of wrinkles on the skin of the hairless mouse was observed and scored according to the criteria shown in Table 2 to evaluate. At this time, a group to which only purified water was applied was used as a control. The results were calculated as the average of each group, and are shown in Table 3 in relation to the number of UVB irradiation days.

【0037】[0037]

【表2】 [Table 2]

【0038】[0038]

【表3】 [Table 3]

【0039】表3より明らかなように、対照において
は、UVB照射日数が10週を越える頃には皮膚に形成
されたしわの深さは中程度にまで達し、20週後には深
いしわの形成が認められていた。これに対し本発明の実
施例塗布群では、いずれにおいても20週後に微小或い
は軽微なしわの形成を認めた程度で、しわの形成は顕著
に抑制されていた。これに対し、野生株の酵母抽出物の
みを含有する比較例1及び比較例3塗布群では明確なし
わ形成抑制効果は見られず、さらに酢酸トコフェロール
等を含有する比較例2及び比較例12と、酵母抽出物を
リポソーム化して含有する比較例6塗布群においても、
若干のしわ形成抑制効果が見られたのみであった。ま
た、紫外線吸収剤やセイヨウトチノキ抽出物,リポ酸を
含有する比較例4,比較例5及び比較例7塗布群では良
好なしわ形成抑制効果が認められていたが、それぞれ対
応する実施例塗布群に比べてその程度は小さかった。
As is apparent from Table 3, in the control, the depth of wrinkles formed on the skin reached a medium level when the number of UVB irradiation days exceeded 10 weeks, and deep wrinkles formed after 20 weeks. Was recognized. On the other hand, in each of the groups to which the examples of the present invention were applied, the formation of minute or slight wrinkles was observed after 20 weeks, and the formation of wrinkles was remarkably suppressed. In contrast, in Comparative Examples 1 and 3 containing only the yeast extract of the wild strain, no clear wrinkle formation-inhibiting effect was observed in the application group, and Comparative Examples 2 and 12 further containing tocopherol acetate and the like. In Comparative Example 6 coated group containing yeast extract in the form of liposome,
Only a slight effect of suppressing wrinkle formation was observed. In addition, the application group of Comparative Example 4, Comparative Example 5 and Comparative Example 7 containing an ultraviolet absorber, a horse chestnut extract and lipoic acid showed a good wrinkle formation-inhibiting effect. The degree was smaller than that of.

【0040】続いて、本発明の実施例1〜実施例12に
ついて使用試験を行い、皮膚の老化症状及び肌荒れ症状
の改善効果を評価した。その際、実施例8〜実施例11
においても、各チオレドキシン高活性酵母抽出物を野生
株のSaccharomyces cerevisiae Meyerにより同様に調製
した酵母抽出物に代替して、比較例8〜比較例11とし
た。
Subsequently, use tests were conducted on Examples 1 to 12 of the present invention to evaluate the effects of improving skin aging and rough skin. At that time, Examples 8 to 11 were used.
Also in Comparative Examples 8 to 11, each thioredoxin highly active yeast extract was replaced with a yeast extract similarly prepared by a wild-type Saccharomyces cerevisiae Meyer.

【0041】皮膚の老化症状の改善効果は、小じわ形成
及び皮膚弾性の低下が認められる40才代〜60才代の
女性パネラー20名を1群とし、各群に実施例及び比較
例のそれぞれをブラインドにて1日2回、2カ月間連続
して使用させて評価した。小じわの程度については肉眼
観察及び写真撮影により評価し、皮膚弾性についてはキ
ュートメーターにより測定して、それぞれ使用試験開始
前及び終了後の状態を比較し、「改善」,「やや改
善」,「変化なし」の3段階で評価した。結果は、各評
価を得たパネラー数にて表4に示した。
The effect of ameliorating the aging of the skin was evaluated by the group consisting of 20 female panelists in their 40s and 60s in which fine wrinkles and decreased skin elasticity were observed. Evaluation was performed by using the product twice a day in a blind for two consecutive months. The degree of fine wrinkles was evaluated by visual observation and photography, and skin elasticity was measured with a cute meter. The conditions before and after the start of the use test were compared, and the results were "improved", "slightly improved", and "changed". None ". The results are shown in Table 4 by the number of panelists who obtained each evaluation.

【0042】肌荒れ症状の改善効果は、顕著な肌荒れ症
状を呈する20才代〜60才代の女性パネラー20名を
1群とし、各群に実施例及び比較例のそれぞれをブライ
ンドにて1日2回、2カ月間連続して使用させて評価し
た。使用試験開始前及び終了後の皮膚の状態を、表5に
示す評価基準に従って評価,点数化し、20名の平均値
を算出して表6に示した。
The improvement effect of the rough skin symptoms was obtained by grouping 20 female panelists in their 20s and 60s who exhibited remarkable rough skin symptoms in each group with the examples and comparative examples being blinded for 2 days a day. The evaluation was carried out for two consecutive months. The skin condition before and after the start of the use test was evaluated and scored according to the evaluation criteria shown in Table 5, and the average value of 20 persons was calculated and shown in Table 6.

【0043】[0043]

【表4】 [Table 4]

【0044】[0044]

【表5】 [Table 5]

【0045】[0045]

【表6】 [Table 6]

【0046】表4より明らかなように、本発明の実施例
塗布群では、小じわについては30%以上、皮膚弾性に
ついては25%以上のパネラーにおいて明確な改善が認
められており、症状の改善を認めないパネラーは存在し
なかった。肌荒れ症状についても、表6に示されるよう
に、全実施例塗布群で良好な改善が認められ、皮膚の状
態はほぼ良好な状態まで改善されていた。
As is evident from Table 4, in the group to which the examples of the present invention were applied, a clear improvement was observed in the panelists with fine wrinkles of 30% or more and skin elasticity of 25% or more. There were no panelists who disapproved. As shown in Table 6, favorable improvement was also observed in the skin roughening symptoms in all the groups applied with the examples, and the skin condition was improved to almost a good condition.

【0047】これに対し比較例塗布群では、表4より明
らかなように、それぞれ対応する実施例塗布群に比べて
小じわ及び皮膚弾性の改善の程度は小さいものであっ
た。また表6より明らかなように、比較例1〜比較例
3,比較例6,比較例8,比較例11及び比較例12塗
布群では、肌荒れの改善は不十分で、比較例4,比較例
5,比較例7,比較例9及び比較例10塗布群では良好
な肌荒れ改善効果が認められたものの、それぞれ対応す
る実施例塗布群に比べてその程度は小さいものであっ
た。
On the other hand, as is clear from Table 4, the degree of improvement in fine wrinkles and skin elasticity was smaller in the comparative example-applied group than in the corresponding example-applied group. Further, as is apparent from Table 6, in the application groups of Comparative Examples 1 to 3, Comparative Example 6, Comparative Example 8, Comparative Example 11, and Comparative Example 12, the improvement of the skin roughness was insufficient, and Comparative Examples 4 and Comparative Examples 5, although a good skin roughness improving effect was observed in the application groups of Comparative Example 7, Comparative Example 9, and Comparative Example 10, the degree was smaller than in the corresponding Example application groups.

【0048】[0048]

【発明の効果】以上詳述したように、本発明により、皮
膚の生理機能を活性化し、肌荒れや皮膚の老化の防止及
び改善に有効な皮膚外用剤を得ることができた。
As described in detail above, according to the present invention, a skin external preparation effective for activating physiological functions of the skin and for preventing and improving skin roughness and skin aging can be obtained.

フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 7/00 A61K 7/00 W X 7/02 7/02 Z 7/035 7/035 7/42 7/42 7/48 7/48 35/72 35/72 A61P 17/00 A61P 17/00 // A61K 38/00 A61K 37/02 (72)発明者 岡野 由利 兵庫県神戸市中央区港島中町6丁目13番地 の1 株式会社ノエビア神戸研究所内 (72)発明者 竹井 増美 滋賀県八日市市岡田町字野上112−1 株 式会社ノエビア滋賀中央研究所内 (72)発明者 河合 徳久 岐阜県本巣郡真正町浅木318番地の1 一 丸ファルコス株式会社内 (72)発明者 箕浦 克子 岐阜県本巣郡真正町浅木318番地の1 一 丸ファルコス株式会社内 Fターム(参考) 4C083 AA071 AA072 AA082 AA112 AB032 AB232 AB242 AB432 AB442 AC012 AC022 AC072 AC102 AC122 AC182 AC212 AC342 AC352 AC422 AC432 AC442 AC472 AC482 AC582 AC782 AC862 AD072 AD092 AD112 AD152 AD162 AD172 AD282 AD532 AD662 CC04 CC05 CC12 CC14 CC19 DD22 DD27 DD31 DD32 DD33 DD41 DD45 EE12 EE16 EE17 4C084 AA02 BA44 CA05 MA63 NA14 ZA892 ZC012 4C087 AA01 AA02 BC11 CA16 MA63 NA14 ZA89 ZC01 Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat II (reference) A61K 7/00 A61K 7/00 W X 7/02 7/02 Z 7/035 7/035 7/42 7/42 7 / 48 7/48 35/72 35/72 A61P 17/00 A61P 17/00 // A61K 38/00 A61K 37/02 (72) Inventor Yuri Okano 6-13 Minatomachi, Minatojima, Chuo-ku, Kobe City, Hyogo Prefecture Noevir Kobe Research Institute Co., Ltd. (72) Inventor Masumi Takei 112-1 Nogami, Okada-cho, Yoka City, Shiga Prefecture Inside Noevir Shiga Central Research Laboratory Co., Ltd. 1 One Maru Falcos Co., Ltd. (72) Katsuko Minoura Inventor, 318 Asagi, Mamasa-cho, Motosu-gun, Gifu Prefecture F-term (Ref.) 4C083 AA071 AA072 AA082 AA112 AB032 AB232 AB242 AB432 AB442 AC012 AC022 AC072 AC102 AC122 AC182 AC212 AC342 AC352 AC422 AC432 AC442 AC472 AC482 AC582 AC782 AC862 AD072 AD092 AD112 AD152 AD162 AD172 AD282 AD53 2 AD662 CC04 CC05 CC12 CC14 CC19 DD22 DD27 DD31 DD32 DD33 DD41 DD45 EE12 EE16 EE17 4C084 AA02 BA44 CA05 MA63 NA14 ZA892 ZC012 4C087 AA01 AA02 BC11 CA16 MA63 NA14 ZA89 ZC01

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 チオレドキシン活性の高い酵母の抽出物
より選択した1種又は2種以上を含有することを特徴と
する、皮膚外用剤。
An external preparation for skin characterized by containing one or more selected from yeast extracts having high thioredoxin activity.
【請求項2】 チオレドキシン活性の高い酵母が、Sacc
haromyces cerevisiae Meyerより分離されたチオレドキ
シン高含有株である、請求項1に記載の皮膚外用剤。
2. The yeast having a high thioredoxin activity is Sacc
The external preparation for skin according to claim 1, which is a thioredoxin-rich strain isolated from haromyces cerevisiae Meyer.
JP2000221726A 2000-07-24 2000-07-24 Skin care preparation Pending JP2002037709A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000221726A JP2002037709A (en) 2000-07-24 2000-07-24 Skin care preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000221726A JP2002037709A (en) 2000-07-24 2000-07-24 Skin care preparation

Publications (1)

Publication Number Publication Date
JP2002037709A true JP2002037709A (en) 2002-02-06

Family

ID=18716078

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000221726A Pending JP2002037709A (en) 2000-07-24 2000-07-24 Skin care preparation

Country Status (1)

Country Link
JP (1) JP2002037709A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003238384A (en) * 2002-02-14 2003-08-27 Fancl Corp Skin care preparation
WO2009025062A1 (en) * 2007-08-20 2009-02-26 Dr.Program Co., Ltd. External preparation for skin
US7725082B2 (en) 2002-12-18 2010-05-25 Panasonic Corp. Radio communication apparatus, radio communication method, antenna apparatus and first duplexer
KR20140060928A (en) * 2012-11-13 2014-05-21 (주)아모레퍼시픽 Skin external composition containing thioredoxin
JP2016216436A (en) * 2015-05-18 2016-12-22 株式会社ファンケル Skin viscoelasticity improver
CN115778837A (en) * 2022-11-21 2023-03-14 安徽品赫生物科技有限公司 Synergistic skin-brightening repair freeze-dried powder and preparation method and application thereof

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003238384A (en) * 2002-02-14 2003-08-27 Fancl Corp Skin care preparation
US7725082B2 (en) 2002-12-18 2010-05-25 Panasonic Corp. Radio communication apparatus, radio communication method, antenna apparatus and first duplexer
WO2009025062A1 (en) * 2007-08-20 2009-02-26 Dr.Program Co., Ltd. External preparation for skin
JP2009046421A (en) * 2007-08-20 2009-03-05 Doctor Program Kk Skin care preparation for external use
JP2015536979A (en) * 2012-11-13 2015-12-24 株式会社アモーレパシフィックAmorepacific Corporation Skin external preparation composition containing thioredoxin
WO2014077568A1 (en) * 2012-11-13 2014-05-22 주식회사 아모레퍼시픽 Composition for external use skin preparation, containing thioredoxin
KR20140060928A (en) * 2012-11-13 2014-05-21 (주)아모레퍼시픽 Skin external composition containing thioredoxin
US20170100320A1 (en) * 2012-11-13 2017-04-13 Amorepacific Corporation Composition for external use skin preparation, containing thioredoxin
JP2018158946A (en) * 2012-11-13 2018-10-11 アモーレパシフィック コーポレーション Composition for external use skin preparation, containing thioredoxin
CN108904319A (en) * 2012-11-13 2018-11-30 株式会社爱茉莉太平洋 Dermatologic preparation composition containing thioredoxin
KR102026800B1 (en) * 2012-11-13 2019-09-30 (주)아모레퍼시픽 Skin external composition containing thioredoxin
JP2016216436A (en) * 2015-05-18 2016-12-22 株式会社ファンケル Skin viscoelasticity improver
CN115778837A (en) * 2022-11-21 2023-03-14 安徽品赫生物科技有限公司 Synergistic skin-brightening repair freeze-dried powder and preparation method and application thereof
CN115778837B (en) * 2022-11-21 2024-04-02 安徽品赫生物科技有限公司 Synergistic skin-brightening and repairing freeze-dried powder and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN112656729A (en) Oil control isolation composition and preparation method and application thereof
KR102016164B1 (en) Whitening emulsion cosmetic composition containing a vitamin tree fruit extract and method for manufacturing the same
EP1486193B1 (en) Method of stabilizing silicone oil-containing cosmetic composition
JP2000044485A (en) Active oxygen species scavenger and skin cosmetic
JP2003104865A (en) Skin care preparation
JP7075177B2 (en) Cosmetics
JP3825882B2 (en) Fibroblast activator and skin external preparation containing the same
JP3667027B2 (en) Topical skin preparation
JP2002037709A (en) Skin care preparation
JP2001114636A (en) Hyaluronic acid production and catalase production promoting agent, fibroblast activating agent and skin lotion
JP2001122733A (en) Catalase production-promoting preparation and skin preparation for external use containing the same
JP2001212445A (en) Emulsifying agent
JP2000096050A (en) Promoter for production of hyaluronic acid
JP3822959B2 (en) Anti-aging skin external preparation
JP2004307437A (en) Skin care preparation for external use for preventing aging
JP3597520B2 (en) External preparation for skin
JP2001114637A (en) Hyaluronic acid production promoting agent and skin lotion containing the agent
JP3449967B2 (en) External preparation for skin
JP4562536B2 (en) Topical skin preparation
JP2004307438A (en) Skin care preparation for external use
JP2004123661A (en) Skin care preparation for external use
JP2004002484A (en) External preparation for skin
JPH10236941A (en) Skin lotion
JP2001151631A (en) Preparation for external use for skin
JPS61254510A (en) External agent for skin

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070709

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20070709

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070709

RD05 Notification of revocation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7425

Effective date: 20080318

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080801

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080902

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090106